COVID-19 vaccine hesitancy among Mexican outpatients with rheumatic diseases

被引:8
|
作者
Guaracha-Basanez, Guillermo [1 ]
Contreras-Yanez, Irazu [1 ]
alvarez-Hernandez, Everardo [2 ]
Roman-Montes, Carla Marina [3 ]
Olguin, Graciela Meza-Lopez Y.
Morales-Graciano, Maria Jose [2 ]
Valverde-Hernandez, Salvador Saul [1 ,2 ]
Pelaez-Ballestas, Ingris [2 ]
Pascual-Ramos, Virginia [1 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Immunol & Rheumatol, Mexico City, DF, Mexico
[2] Hosp Gen Mexico Dr Eduardo Liceaga, Dept Rheumatol, Mexico City, DF, Mexico
[3] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Infect Dis Dept, Mexico City, DF, Mexico
关键词
Covid-19; vaccine; vaccine hesitancy; rheumatic diseases patients; PATIENT-REPORTED OUTCOMES; CHALLENGES; AUTOIMMUNE;
D O I
10.1080/21645515.2021.2003649
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Vaccine hesitancy (VH) has emerged as a recognized threaten to contain the COVID-19 pandemic. Historically, low vaccine acceptance rates had been described among patients with rheumatic diseases (RMDs). The study objective was to determine COVID-19 VH among Mexican outpatients with RMDs and validate the COVID-19 VH questionnaire. This cross-sectional study was developed in three steps. Step 1 consisted of translation/cultural adaptation of the Oxford-COVID-19-VH questionnaire. Step 2 consisted of pilot testing and questionnaire feasibility, content, construct and criterion validity, reliability (internal consistency and temporal stability) and questionnaire sensitivity to change. Step 3 consisted of VH phenomenon quantification in patients from two metropolitan tertiary-care-level centers. Step 1 followed ISPOR-task-force recommendations. Patients who participated in step 2 (n = 50 for pilot testing/feasibility and n = 208 for questionnaire validation [91 in test-retest and 70 in questionnaire-sensitivity to change]) and step 3 (n = 600) were representative outpatients with RMDs. The seven-item COVID-19 VH questionnaire was found feasible, valid (experts' agreement >= 80%; a 1-factor structure accounted for 60.73% of the total variance; rho = 0.156, p = .025 between COVID-19 VH questionnaire and score from the Spanish version of the Vaccine Hesitancy Scale; and lower questionnaire scores in patients who reported 5 years-previous influenza vaccination), reliable (Cronbach's alpha = 0.889, intra-class correlation coefficient = 0.933 and 95% confidence interval = 0.898-0.956) and sensitive to change (effect size = 1.17 and 0.86, respectively, in patients who decreased [n = 34] and increased [n = 31] questionnaire-score after intervention). VH phenomenon was 35.5%. VH phenomenon was present in a substantial number of Mexican patients with RMDs. The COVID-19 VH questionnaire showed good psychometric properties to assess COVID-19 VH in our population.
引用
收藏
页码:5038 / 5047
页数:10
相关论文
共 50 条
  • [1] COVID-19 Vaccine Hesitancy Among Patients with Rheumatic and Other Diseases
    Valerio, Valeria
    Rampakakis, Emmanouil
    Hudson, Marie
    Bernatsky, Sasha
    Hazel, Elizabeth M.
    Colmegna, Ines
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3255 - 3257
  • [2] Factors Associated with COVID-19 Vaccine Hesitancy Among Individuals with Rheumatic Disease
    Wipfler, Kristin
    Cornish, Adam
    Freifeld, Alison
    Katz, Patricia
    Michaud, Kaleb
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3366 - 3369
  • [3] COVID-19 vaccine hesitancy among youth
    Willis, Don E.
    Presley, Jessica
    Williams, Mark
    Zaller, Nickolas
    McElfish, Pearl A.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (12) : 5013 - 5015
  • [4] Assessment of hesitancy to COVID-19 vaccine in patients with rheumatic arthritis
    Zeng, H. -Q.
    Liu, H. -J.
    Wang, S. -B.
    Yin, Z. -H.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (16) : 7459 - 7469
  • [5] COVID-19 Vaccine Hesitancy among Parents of Children with Chronic Liver Diseases
    Elkhadry, Sally Waheed
    Salem, Tahany Abd El Hameed
    Elshabrawy, Abdelhamid
    Goda, Shymaa Sami
    Bahwashy, Howyda Ali Al
    Youssef, Naglaa
    Hussein, Mai
    Ghazy, Ramy Mohamed
    [J]. VACCINES, 2022, 10 (12)
  • [6] Correlates of the COVID-19 Vaccine Hesitancy Among Indians
    Bansal, Prateek
    Raj, Alok
    Sinha, Rajesh Kumar
    [J]. ASIA-PACIFIC JOURNAL OF PUBLIC HEALTH, 2022, 34 (05) : 583 - 585
  • [7] COVID-19 VACCINE PERCEPTION AND HESITANCY AMONG PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASE (AIRD) IN MALAYSIA
    Shaharir, S. S.
    Kamaruzaman, L.
    Mariamutu, T. N.
    Said, M. S. Mohamed
    Nawi, A. Mohammed
    Ghazali, W. S. Wan
    Noh, M. Mohd
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1908 - 1909
  • [8] COVID-19 VACCINE HESITANCY AMONG UNDERSERVED POPULATIONS
    Rawal, S.
    Tackett, R.
    Osae, S. P.
    Young, H. N.
    [J]. RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2023, 19 (03): : 568 - 568
  • [9] COVID-19 Vaccine Hesitancy Among Pregnant Women
    Alkhalifah, Manal
    AlHusseini, Noara
    McGhee, John
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [10] COVID-19 vaccine hesitancy among rural Oklahomans
    Hubach, Randolph D.
    Shannon, Bryan
    Morgan, Kerry D.
    Alexander, Caleb
    O'Neil, Andrew M.
    Ernst, Campbell
    Giano, Zachary
    [J]. RURAL AND REMOTE HEALTH, 2022, 22 (02):